(Q36938002)

17 August 2017

1 reference

title

Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease (English)

1 reference

17 August 2017

Kevin J Liner

1

1 reference

17 August 2017

Colin D Hall

series ordinal

2

1 reference

17 August 2017

Kevin R Robertson

series ordinal

3

1 reference

17 August 2017

1 August 2007

1 reference

17 August 2017

Journal of NeuroVirology

1 reference

17 August 2017

13

1 reference

17 August 2017

4

1 reference

17 August 2017

291-304

1 reference

https://scigraph.springernature.com/pub.10.1080/13550280701422383

17 August 2017

0 references

cites work

Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance

1 reference

12 December 2020

Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal

1 reference

12 December 2020

Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions

1 reference

12 December 2020

Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

1 reference

12 December 2020

HIV-1 nomenclature proposal.

1 reference

12 December 2020

Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand

1 reference

12 December 2020

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

1 reference

12 December 2020

Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement

1 reference

12 December 2020

HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region

1 reference

12 December 2020

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

1 reference

12 December 2020

Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors

1 reference

12 December 2020

The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures

1 reference

12 December 2020

Cell death in HIV dementia

1 reference

12 December 2020

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

1 reference

12 December 2020

A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

1 reference

12 December 2020

Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms

1 reference

12 December 2020

The accuracy of reverse transcriptase from HIV-1.

1 reference

12 December 2020

Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution

1 reference

12 December 2020

Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.

1 reference

12 December 2020

Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir

1 reference

12 December 2020

Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis.

1 reference

12 December 2020

Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial

1 reference

12 December 2020

Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates

1 reference

12 December 2020

Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

1 reference

12 December 2020

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

12 December 2020

Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1

1 reference

12 December 2020

Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.

1 reference

12 December 2020

Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method

1 reference

12 December 2020

The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines

1 reference

12 December 2020

Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma.

1 reference

12 December 2020

Global epidemiology of HIV.

1 reference

12 December 2020

Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

1 reference

12 December 2020

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

1 reference

12 December 2020

Selective neuronal vulnerability in HIV encephalitis

1 reference

12 December 2020

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

HIV-1 subtype and second-receptor use

1 reference

12 December 2020

Detection of HIV‐1 DNA in Microglia/ Macrophages, Astrocytes and Neurons Isolated from Brain Tissue with HIV‐1 Encephalitis by Laser Capture Microdissection

1 reference

12 December 2020

Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus

1 reference

12 December 2020

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

1 reference

12 December 2020

Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

1 reference

12 December 2020

Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation.

1 reference

12 December 2020

Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses

1 reference

12 December 2020

HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS.

1 reference

12 December 2020

Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex

1 reference

12 December 2020

HIV-1 drug resistance in newly infected individuals

1 reference

12 December 2020

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients

1 reference

12 December 2020

An experimental model system for HIV-1-induced brain injury

1 reference

12 December 2020

Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast

1 reference

12 December 2020

Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results

1 reference

12 December 2020

Group O human immunodeficiency virus-1 infections

1 reference

12 December 2020

Molecular cloning and polymorphism of the human immune deficiency virus type 2.

1 reference

12 December 2020

Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore

1 reference

12 December 2020

HIV-1 group O sensitivity to antiretroviral drugs

1 reference

12 December 2020

Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients

1 reference

12 December 2020

Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort

1 reference

12 December 2020

Retrovirus infections of the nervous system

1 reference

12 December 2020

Predictors of rapid progression to AIDS in HIV-1 seroconverters

1 reference

12 December 2020

Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients.

1 reference

12 December 2020

Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells

1 reference

12 December 2020

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

12 December 2020

Human immunodeficiency virus type 2

1 reference

12 December 2020

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

12 December 2020

Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences

1 reference

12 December 2020

Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load

1 reference

12 December 2020

Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS.

1 reference

12 December 2020

Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity

1 reference

12 December 2020

AIDS as a zoonosis: scientific and public health implications

1 reference

12 December 2020

Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use.

1 reference

12 December 2020

CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.

1 reference

12 December 2020

HIV-1 subtypes: epidemiology and significance for HIV management

1 reference

12 December 2020

Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases

1 reference

12 December 2020

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

1 reference

12 December 2020

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

1 reference

12 December 2020

Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness

1 reference

12 December 2020

Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia

1 reference

12 December 2020

Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses

1 reference

12 December 2020

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

12 December 2020

Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.

1 reference

12 December 2020

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon.

1 reference

12 December 2020

HIV diversity, molecular epidemiology, and the role of recombination.

1 reference

12 December 2020

The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha.

1 reference

12 December 2020

Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.

1 reference

12 December 2020

Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy.

1 reference

12 December 2020

Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance

1 reference

12 December 2020

Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence

1 reference

12 December 2020

Molecular epidemiology of HIV.

1 reference

12 December 2020

Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British Columbia.

1 reference

12 December 2020

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

1 reference

12 December 2020

Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

1 reference

12 December 2020

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

12 December 2020

Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D.

1 reference

12 December 2020

Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat.

1 reference

12 December 2020

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus

1 reference

12 December 2020

HIV-1 dynamics in vivo: implications for therapy

1 reference

12 December 2020

Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease.

1 reference

12 December 2020

Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).

1 reference

12 December 2020

HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons

1 reference

12 December 2020

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

12 December 2020

What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective.

1 reference

12 December 2020

Chemokine receptors: keys to AIDS pathogenesis?

1 reference

12 December 2020

Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma

1 reference

12 December 2020

Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype

1 reference

12 December 2020

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

1 reference

12 December 2020

Analysis of Mutations Made during Active Synthesis or Extension of Mismatched Substrates Further Define the Mechanism of HIV-RT Mutagenesis

1 reference

12 December 2020

Viral and Cellular Factors Influencing HIV Tropism

1 reference

12 December 2020

Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals

1 reference

12 December 2020

Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis

1 reference

12 December 2020

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

1 reference

12 December 2020

Slower heterosexual spread of HIV-2 than HIV-1.

1 reference

12 December 2020

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

1 reference

12 December 2020

A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease

1 reference

12 December 2020

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

1 reference

12 December 2020

HIV-1 subtype E progression among northern Thai couples: traditional and non-traditional predictors of survival

1 reference

12 December 2020

Fidelity of HIV-1 reverse transcriptase

1 reference

12 December 2020

Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India

1 reference

12 December 2020

gp120-induced alterations of human astrocyte function: Na(+)/H(+) exchange, K(+) conductance, and glutamate flux

1 reference

12 December 2020

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda

1 reference

12 December 2020

Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery

1 reference

12 December 2020

Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations.

1 reference

12 December 2020

Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection

1 reference

12 December 2020

Cross-species transmission and recombination of ‘AIDS’ viruses

1 reference

12 December 2020

Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells

1 reference

12 December 2020

Human immunodeficiency virus type 1 subtypes differ in disease progression

1 reference

12 December 2020

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

1 reference

12 December 2020

Integration is not necessary for expression of human immunodeficiency virus type 1 protein products

1 reference

12 December 2020

Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity

1 reference

12 December 2020

HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV.

1 reference

12 December 2020

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

1 reference

12 December 2020

Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france

1 reference

12 December 2020

Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.

1 reference

12 December 2020

HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists

1 reference

12 December 2020

HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells.

1 reference

12 December 2020

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion

1 reference

12 December 2020

The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection

1 reference

12 December 2020

Genetic diversification and recombination of HIV type 1 group M in Kinshasa, Democratic Republic of Congo.

1 reference

12 December 2020

10.1080/13550280701422383

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference